Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.33 USD | +1.53% | -7.64% | +95.59% |
Apr. 18 | Imunon Receives FDA Approval to Start Phase 1 Trial of COVID-19 Booster Vaccine | MT |
Apr. 18 | Imunon Shares Rise 8% After Clearance to Start Phase 1 Trial for Covid-19 Booster Vaccine | DJ |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 12.5M |
---|---|---|---|---|---|
Net income 2024 * | -23M | Net income 2025 * | -26M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.59
x | P/E ratio 2025 * |
-0.78
x | Employees | 33 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.85% |
Latest transcript on Imunon, Inc.
1 day | +1.53% | ||
1 week | -7.64% | ||
Current month | +1.53% | ||
1 month | -4.32% | ||
3 months | +141.82% | ||
6 months | +29.13% | ||
Current year | +95.59% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Tardugno
CHM | Chairman | 73 | 07-01-02 |
Jeffrey Church
DFI | Director of Finance/CFO | 67 | 10-07-05 |
Sebastien Hazard
CTO | Chief Tech/Sci/R&D Officer | 53 | Dec. 10 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 56 | 21-06-07 | |
Frederick Fritz
BRD | Director/Board Member | 73 | 11-07-07 |
James Dentzer
BRD | Director/Board Member | 57 | 22-10-02 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 1.33 | +1.53% | 54,612 |
24-05-02 | 1.31 | 0.00% | 21,542 |
24-05-01 | 1.31 | 0.00% | 35,139 |
24-04-30 | 1.31 | -3.31% | 27,432 |
24-04-29 | 1.355 | -5.92% | 64,006 |
Delayed Quote Nasdaq, May 03, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+95.59% | 12.5M | |
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+6.79% | 14.16B | |
+38.61% | 12.63B |
- Stock Market
- Equities
- IMNN Stock